If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma

Cascioferro, S., Li Petri, G., Parrino, B., el Hassouni, B., Carbone, D., Arizza, V., Perricone, U., Padova, A., Funel, N., Peters, G. J., Cirrincione, G., Giovannetti, E. & Diana, P., 2020, In : Molecules. 25, 2, E329.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

Van Der Steen, N., Keller, K., Dekker, H., Porcelli, L., Honeywell, R. J., Van Meerloo, J., Musters, R. J. P., Kathmann, I., Frampton, A. E., Liu, D. S. K., Ruijtenbeek, R., Rolfo, C., Pauwels, P., Giovannetti, E. & Peters, G. J., 1 Jan 2020, In : Journal of Cellular Physiology.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-κB signaling pathways

Rahmani, F., Asgharzadeh, F., Avan, A., Barneh, F., Parizadeh, M. R., Ferns, G. A., Ryzhikov, M., Ahmadian, M. R., Giovannetti, E., Jafari, M., Khazaei, M. & Hassanian, S. M., 15 May 2020, In : Life Sciences. 249, 117470.

Research output: Contribution to journalArticleAcademicpeer-review

2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitors

Cascioferro, S., Parrino, B., Petri, G. L., Cusimano, M. G., Schillaci, D., di Sarno, V., Musella, S., Giovannetti, E., Cirrincione, G. & Diana, P., 1 Apr 2019, In : European Journal of Medicinal Chemistry. 167, p. 200-210 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Activities

  • 2 Oral presentation

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma

LL Meijer (Speaker), C Caparello (Speaker), TYS Le Large (Speaker), BM Zonderhuis (Speaker), F Daams (Speaker), E Giovannetti (Speaker), G Kazemier (Speaker)
May 2017

Activity: Talk or presentationOral presentation

Plasma microRNAs predict progression in patients with advanced pancreatic ductal adenocarcinoma treated with FOLFIRINOX chemotherapy

LL Meijer (Speaker), C Caparello (Speaker), TYS Le Large (Speaker), G Kazemier (Speaker), E Giovannetti (Speaker)
Jun 2017

Activity: Talk or presentationOral presentation